Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease

Fangda Leng1,2, Rainer Hinz3, Steve Gentleman1

  • 1Department of Brain Sciences, Imperial College London, London, UK.

Molecular Psychiatry
|December 6, 2022
PubMed

Insights

Neuroinflammation, not amyloid plaques, is linked to brain network disruption in Alzheimer's disease (AD). This study shows that microglial activation correlates with impaired brain connectivity, suggesting a pathway from inflammation to AD dysfunction.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Background:

  • Brain network dysfunction is a hallmark of Alzheimer's disease (AD), but its underlying causes remain unclear.
  • Neuroinflammation, involving microglia, is increasingly recognized as a key factor in AD pathogenesis.
  • Pro-inflammatory microglia can disrupt healthy neuronal circuits, contributing to disease progression.

Purpose of the Study:

  • To investigate the independent association between microglial activation and brain connectivity disruption in Alzheimer's disease.
  • To explore the relationship between neuroinflammation, amyloid-beta (Aβ) deposition, brain network integrity, and cognitive function.
  • To differentiate the roles of neuroinflammation and Aβ in AD-related network changes.

Main Methods:

  • A cross-sectional multimodal imaging study involving 42 participants (Aβ-positive MCI, Aβ-positive AD, and Aβ-negative controls).
  • Utilized PET imaging (¹¹C-PBR28 for microglial activation, ¹⁸F-flutemetamol for Aβ deposition) and MRI (T1-weighted, diffusion tensor, resting-state functional MRI) to assess brain structure and function.
  • Analyzed correlations between neuroinflammation markers, Aβ load, network properties (structural integrity, functional organization), and cognitive scores.

Main Results:

  • Alzheimer's disease patients exhibited increased microglial activation (¹¹C-PBR28 uptake) and decreased network integrity (FA, small-worldness, local efficiency).
  • Cortical microglial activation negatively correlated with structural integrity and local network efficiency, independent of cortical thickness and Aβ deposition.
  • Aβ deposition did not show a similar independent association with network disruption.

Conclusions:

  • Cortical neuroinflammation is associated with structural and functional brain network disruption in Alzheimer's disease, independent of Aβ pathology and atrophy.
  • These findings highlight a potential pathway from neuroinflammation to widespread brain dysfunction in AD.
  • Targeting neuroinflammation may offer a therapeutic strategy for mitigating network disruption and cognitive decline in Alzheimer's disease.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
612
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
729